Insmed Inc (NASDAQ:INSM)
| 38.31 Delayed Data As of 3:59pm ET |  -3.94 / -9.34%Today’s Change | 12.09 Today|||52-Week Range 44.37 | +15.06% Year-to-Date |
Latest INSM News | Press Releases
No recent news for Insmed Inc.
Today’s Trading
| Previous close | 42.25 |
| Today’s open | 41.20 |
| Day’s range | 37.51 - 41.29 |
| Volume | 76,728 |
| Average volume (3 months) | 873,990 |
| Market cap | $4.3B |
Data as of 3:59pm ET, 01/27/2021
Growth & Valuation
| Earnings growth (last year) | +28.68% |
| Earnings growth (this year) | +14.61% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +1,287.56% |
| P/E ratio | NM |
| Price/Sales | 14.80 |
| Price/Book | 14.39 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RETAReata Pharmaceutical... | -9.75 | -8.33% |
| PTCTPTC Therapeutics Inc | -4.64 | -7.58% |
| ARNAArena Pharmaceutical... | -1.89 | -2.48% |
| CCXIChemoCentryx Inc | -2.89 | -4.87% |
Data as of 3:59pm ET, 01/27/2021
Financials
| Next reporting date | February 25, 2021 |
| EPS forecast (this quarter) | -$0.65 |
| Annual revenue (last year) | $136.5M |
| Annual profit (last year) | -$254.3M |
| Net profit margin | -186.37% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
